Q32 BIO INC (QTTB) Stock Balance Sheet
NASDAQ:QTTB - Nasdaq - US7469641051 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 749.00K | 0.00 | 100.00K | 300.00K | |||
| Cash Equivalents | 89.08M | 38.52M | 34.00M | 108.30M | 217.20M | |||
| Marketable Securities | N/A | 43.39M | 141.00M | 47.50M | 0.00 | |||
| Receivables | 563.00K | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 4.26M | 1.26M | 6.00M | 36.00M | 2.10M | |||
| Total Current Assets | 93.90M | 83.91M | 181.00M | 191.90M | 219.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.36M | 650.00K | 21.60M | 17.90M | 42.90M | |||
| Investments And Advances | 2.60M | 0.00 | 25.80M | N/A | N/A | |||
| Other Non-Current Assets | 687.00K | N/A | 0.00 | 2.00M | 1.30M | |||
| Total Non-Current Assets | 10.64M | 650.00K | 47.50M | 19.80M | 44.10M | |||
| TOTAL ASSETS | 104.54M | 84.56M | 228.50M | 211.70M | 263.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.53M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 8.91M | 8.34M | 20.30M | 11.70M | 12.30M | |||
| Accounts Payable | 1.26M | 3.23M | 1.10M | 2.40M | 4.70M | |||
| Other Current Liabilities | 2.68M | 0.00 | 1.20M | 3.20M | 5.60M | |||
| Total Current Liabilities | 14.38M | 11.57M | 22.60M | 17.20M | 22.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 11.07M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 60.79M | 0.00 | 27.90M | 24.80M | 45.10M | |||
| Total Non-Current Liabilities | 71.86M | 0.00 | 27.90M | 24.90M | 45.00M | |||
| TOTAL LIABILITIES | 86.25M | 11.57M | 50.50M | 42.10M | 67.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -220.63M | -542.10M | -429.10M | -424.10M | -328.40M | |||
| Additional Paid In Capital | 238.92M | 615.09M | 607.50M | 593.80M | 524.40M | |||
| Common Shares | 2.00K | 6.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 12.14M | 3.22M | 57.50M | 57.20M | 50.30M | |||
| Tangible Book Value per Share | 1.51 | 22.64 | 3.10 | 2.97 | 3.90 | |||
| Total Shareholders' Equity | 18.30M | 72.99M | 178.00M | 169.70M | 196.00M | |||
| TOTAL LIABILITIES AND EQUITY | 104.54M | 84.56M | 228.50M | 211.70M | 263.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.61 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 6.53 | 7.25 | 8.01 | 11.16 | 9.67 | |||
| Return On Assets (ROA) | -47.51% | -133.58% | -2.19% | -45.23% | -48.80% | |||
| Return On Equity (ROE) | -271.46% | -154.76% | -2.81% | -56.43% | -65.66% | |||
All data in USD , ROIC based on taxRate of 0.21